| Author (Person) | Buck, Tobias, Jack, Andrew |
|---|---|
| Series Title | Financial Times |
| Series Details | 16.6.05 |
| Publication Date | 16/06/2005 |
| Content Type | News |
|
Anglo-Swedish pharmaceutical group AstraZeneca is to appeal against a € 60 million fine from the European Commission for misusing the patent system and the procedures for marketing pharmaceuticals to block or delay market entry for generic competitors to its ulcer drug Losec. |
|
| Related Links |
|
| Subject Categories | Business and Industry, Internal Markets |
| Countries / Regions | Europe |
